Pharmacokinetics of apatinib in healthy male Caucasian, Japanese and Chinese subjects.

Trial Profile

Pharmacokinetics of apatinib in healthy male Caucasian, Japanese and Chinese subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Sep 2017

At a glance

  • Drugs Apatinib (Primary)
  • Indications Breast cancer; Colorectal cancer; Fallopian tube cancer; Gastric cancer; Hepatocellular carcinoma; Non-small cell lung cancer; Ovarian cancer; Peritoneal cancer; Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Sep 2017 New trial record
    • 01 Sep 2017 Results assessing Pharmacokinetics of apatinib in healthy Caucasian, Japanese and Chinese subjects following a single-dose administration, were published in the Clinical Pharmacology in Drug Development Conference: 2017 Annual Meeting of the American College of Clinical Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top